NCT06465706View on ClinicalTrials.gov

Assessing the Safety and Efficacy of the LAmbre™ Plus Device

NANot yet recruitingINTERVENTIONAL

Enrollment

1,826

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

October 1, 2029

Study Completion Date

January 31, 2030

Conditions

Atrial Fibrillation

Interventions

DEVICE

LAmbre investigational device

Randomized 1:1 to either experimental group or control group.

All Listed Sponsors

lead

Kansas City Heart Rhythm Research Foundation

OTHER